Decentralized clinical trials and rare diseases: a Drug Information Association Innovative Design Scientific Working Group (DIA-IDSWG) perspective.

MLA

Ghadessi, Mercedeh, et al. “Decentralized Clinical Trials and Rare Diseases: A Drug Information Association Innovative Design Scientific Working Group (DIA-IDSWG) Perspective.” Orphanet Journal of Rare Diseases, vol. 18, no. 1, Apr. 2023, p. 79. EBSCOhost, https://doi.org/10.1186/s13023-023-02693-7.

APA

Ghadessi, M., Di, J., Wang, C., Toyoizumi, K., Shao, N., Mei, C., Demanuele, C., Tang, R. S., McMillan, G., & Beckman, R. A. (2023). Decentralized clinical trials and rare diseases: a Drug Information Association Innovative Design Scientific Working Group (DIA-IDSWG) perspective. Orphanet Journal of Rare Diseases, 18(1), 79. https://doi.org/10.1186/s13023-023-02693-7

Chicago

Ghadessi, Mercedeh, Junrui Di, Chenkun Wang, Kiichiro Toyoizumi, Nan Shao, Chaoqun Mei, Charmaine Demanuele, Rui Sammi Tang, Gianna McMillan, and Robert A Beckman. 2023. “Decentralized Clinical Trials and Rare Diseases: A Drug Information Association Innovative Design Scientific Working Group (DIA-IDSWG) Perspective.” Orphanet Journal of Rare Diseases 18 (1): 79. doi:10.1186/s13023-023-02693-7.